Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: Association with liver fibrosis

Metabolism: Clinical and Experimental

Volumn 59, Issue 9, 2010, Pages 1327-1330

  Yilmaz, Yusuf ^a   Alahdab, Yesim Ozen ^a   Yonal, Oya ^a   Kurt, Ramazan ^a   Kedrah, Alla Eldeen ^a   Celikel, Cigdem Ataizi ^a   Ozdogan, Osman ^a   Duman, Deniz ^a   Imeryuz, Nese ^a   Avsar, Erol ^a   Kalayci, Cem ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; FEMALE; HUMAN; INSULIN RESISTANCE; LIVER BIOPSY; LIVER FIBROSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; TURKEY (REPUBLIC); ALBUMINURIA; BODY MASS; CHI SQUARE DISTRIBUTION; FATTY LIVER; LIVER; LIVER CIRRHOSIS; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; AGED; ALBUMINURIA; BODY MASS INDEX; CHI-SQUARE DISTRIBUTION; FATTY LIVER; FEMALE; HUMANS; INSULIN RESISTANCE; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; TURKEY;

EID: 77956625813     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.12.012     Document Type: Article

References (20)

1. Sass D.A., Chang P., and Chopra K.B. Nonalcoholic fatty liver disease: a clinical review Dig Dis Sci 50 2005 171 180
2. Tilg H., and Moschen A.R. Insulin resistance, inflammation, and non-alcoholic fatty liver disease Trends Endocrinol Metab 19 2008 371 379
3. Utzschneider K.M., and Kahn S.E. Review: the role of insulin resistance in nonalcoholic fatty liver disease J Clin Endocrinol Metab 91 2006 4753 4761
4. Chen J., Muntner P., Hamm L.L., Jones D.W., Batuman V., and Fonseca V. The metabolic syndrome and chronic kidney disease in U.S. adults Ann Intern Med 140 2004 167 174
5. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation Diabet Med 15 1998 539 553
6. Jager A., Kostense P.J., Nijpels G., Heine R.J., Bouter L.M., and Stehouwer C.D. Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome : the Hoorn study Diabetologia 41 1998 694 700
7. Balkau B., and Charles M.A. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR) Diabet Med 16 1999 442 443
8. Hwang S.T., Cho Y.K., Yun J.W., Park J.H., Kim H.J., and Park D.I. Impact of NAFLD on microalbuminuria in patients with prediabetes and diabetes Intern Med J 2009 10.1111/j.1445-5994.2009.01979.x
9. Targher G., Bertolini L., Padovani R., Poli F., Scala L., and Zenari L. Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients J Endocrinol Invest 29 2006 55 60 (Pubitemid 43355836)
10. Manco M., Ciampalini P., DeVito R., Vania A., Cappa M., and Nobili V. Albuminuria and insulin resistance in children with biopsy proven non-alcoholic fatty liver disease Pediatr Nephrol 24 2009 1211 1217
11. Angulo P. Nonalcoholic fatty liver disease N Engl J Med 346 2002 1221 1231
12. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., and Cummings O.W. Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
13. Chang Y., Ryu S., Sung E., Woo H.Y., Oh E., and Cha K. Nonalcoholic fatty liver disease predicts chronic kidney disease in non-hypertensive and non-diabetic Korean men Metabolism 57 2008 569 576
14. Satchell S.C., and Tooke J.E. What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium? Diabetologia 51 2008 714 725
15. Parvanova A.I., Trevisan R., Iliev I.P., Dimitrov B.D., Vedovato M., and Tiengo A. Insulin resistance and microalbuminuria: a cross-sectional, case-control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretion Diabetes 55 2006 1456 1462
16. Lonardo A., Carani C., Carulli N., and Loria P. 'Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis J Hepatol 44 2006 1196 1207
17. Georgescu E.F. Angiotensin receptor blockers in the treatment of NASH/NAFLD: could they be a first-class option? Adv Ther 25 2008 1141 1174
18. Almeda-Valdés P., Cuevas-Ramos D., and Aguilar-Salinas C.A. Metabolic syndrome and non-alcoholic fatty liver disease Ann Hepatol 8 2009 S18 24
19. Parsons C.J., Takashima M., and Rippe R.A. Molecular mechanisms of hepatic fibrogenesis J Gastroenterol Hepatol 22 2007 S79 84
20. Zhu S., Liu Y., Wang L., and Meng Q.H. Transforming growth factor-beta1 is associated with kidney damage in patients with essential hypertension: renoprotective effect of ACE inhibitor and/or angiotensin II receptor blocker Nephrol Dial Transplant 23 2008 2841 2846